Tsubota Laboratory Incorporated (TSE: 4890)
Health Care · Pharmaceuticals · JP
¥277.00
+6.54% today · -25.5% 1Y
Tsubota Laboratory Incorporated (TSE: 4890) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $44.94M and employs 22 people.
Over the last twelve months the share price has lost 25.5%, trading between 210.00 and 478.00.
Tweenvest scores Tsubota Laboratory Incorporated across four factors: quality 50/100, value 59/100, growth 0/100. Its strongest factor is value.
4890 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $44.94M
- Revenue (TTM)
- $2.40M
- P/E
- —
- EPS
- -26.89
- Dividend yield
- —
- Beta (5Y)
- 1.15
- 52-week high
- ¥478.00
- 52-week low
- ¥210.00
- Avg volume (3M)
- —
- Shares outstanding
- 25.79M
- Employees
- 22
- Next earnings
- —
About Tsubota Laboratory Incorporated
Operating from Tokyo, Japan since its establishment in 2012, Tsubota Laboratory Incorporated is dedicated to the research and development of pharmaceutical products and medical devices, specifically targeting the treatment of myopia, dry eyes, and presbyopia.
- ISIN
- JP3535700003
- Founded
- 2012
- Listed since
- Jun 23, 2022
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,232.45 | -0.10% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $272.93 | -0.08% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF371.90 | -0.51% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.29 | -1.18% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.